We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers Guidelines for Drug Metabolite Safety Testing
FDA Offers Guidelines for Drug Metabolite Safety Testing
June 6, 2005
Manufacturers should attempt to identify differences in drug metabolism between animals used in nonclinical safety assessments and humans as early as possible during the drug development process to ensure timely assessment of potential safety issues, the FDA recommends in a draft guidance.